Sharp Therapeutics Corp.
SHRXF
$3.00
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 117.18% | -2,787.84% | 0.00% | 93.76% | -46.76% |
| Total Depreciation and Amortization | -14.50% | 8.03% | 0.00% | 200.00% | -80.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -198.18% | 321.38% | 0.00% | -236.66% | 5.34% |
| Change in Net Operating Assets | 116.12% | 22.66% | 0.00% | -142.78% | 1,381.11% |
| Cash from Operations | 3.38% | -17.66% | 0.00% | -74.38% | -13.08% |
| Capital Expenditure | -- | -- | -- | -100.00% | 153.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00% | -- | -- |
| Cash from Investing | -- | -- | 0.00% | -84.34% | 153.38% |
| Total Debt Issued | -- | -- | 0.00% | -62.00% | -- |
| Total Debt Repaid | 0.00% | 70.31% | 0.00% | -236.80% | 0.00% |
| Issuance of Common Stock | -- | -- | 0.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00% | -- | -- |
| Cash from Financing | 4,964.20% | -101.78% | 0.00% | 133.58% | 166.67% |
| Foreign Exchange rate Adjustments | 276.54% | -966.67% | 0.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 177.16% | -190.33% | 0.00% | 4,166.14% | 121.04% |